| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |